Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug Discovery and Development for Heart Failure Using Multi-Omics Approaches

17 Mar 2025

Abstract excerpt

Heart failure (HF) is a complex, heterogeneous syndrome with rising prevalence and high morbidity and mortality. The pathophysiology and diverse etiologies of HF present significant challenges for developing effective therapies. Omics technologies-including genomics, proteomics, transcriptomics, metabolomics, and epigenomics-have reshaped our understanding of HF at the molecular level, uncovering new biomarkers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Function and Risk Factors
Share to Heart Failure Treatment and Management

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40141349
DOI: 10.3390/ijms26062703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug Discovery and Development for Heart Failure Using Multi-Omics ApproachesPMID 40141349Read ↗

Omics phenotyping in heart failure: the next frontierSemantic proximity Read ↗

Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart AssociationSemantic proximity Read ↗

404-Error “Disease Not Found”: Unleashing the Translational Potential of -Omics Approaches Beyond Traditional Disease Classification in Heart Failure ResearchSemantic proximity Read ↗

Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction.Semantic proximity Read ↗

Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized MedicineSemantic proximity Read ↗

The emerging role of pharmacogenomics in the treatment of patients with heart failure.Semantic proximity Read ↗

An 'Omics' Perspective on Cardiomyopathies and Heart Failure.Semantic proximity Read ↗

Towards Precision in HF Pharmacotherapy.Semantic proximity Read ↗

Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart FailureSemantic proximity Read ↗

Heart Failure in the Molecular Era: Redefining Our Understanding of Disease Mechanisms and PerspectivesSemantic proximity Read ↗

Metabolic Heterogeneity Across Heart Failure Subtypes Defined by Integrative Multi-Omics Analysis.Semantic proximity Read ↗

Rationale and Design of the HeartShare/AMP-HF Deep Phenotyping Study to Improve Understanding of Heart Failure With Preserved Ejection Fraction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.